Meta Platforms, Inc. – Consensus Indicates Potential 45.5% Upside

DirectorsTalk Interviews

Meta Platforms, Inc. found using ticker (META) now have 54 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 466 and 140 calculating the mean target price we have 235.77. Now with the previous closing price of 162.06 this indicates there is a potential upside of 45.5%. The 50 day moving average now sits at 167.22 while the 200 day moving average is 223.04. The company has a market cap of $454,599m. Company Website: https://investor.fb.com

The potential market cap would be $661,365m based on the market concensus.

Meta Platforms, Inc. develops products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, wearables, and in-home devices worldwide. It operates in two segments, Family of Apps and Reality Labs. The Family of Apps segment’s products include Facebook, which enables people to share, discover, and connect with interests; Instagram, a community for sharing photos, videos, and private messages, as well as feed, stories, reels, video, live, and shops; Messenger, a messaging application for people to connect with friends, family, groups, and businesses across platforms and devices through chat, audio and video calls, and rooms; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact privately. The Reality Labs segment provides augmented and virtual reality related products comprising virtual reality hardware, software, and content that help people feel connected, anytime, and anywhere. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. Meta Platforms, Inc. was incorporated in 2004 and is headquartered in Menlo Park, California.

Share on:

Latest Company News

Genflow Biosciences reports continued SIRT6 progress in first half of 2026

Genflow Biosciences reported positive interim and three-month follow-up results from its SLAB canine trial, expanded animal health partnerships, secured a fully funded LNP collaboration with Acuitas Therapeutics and strengthened its SIRT6 patent portfolio.

Real Estate Credit Investments (RECI) FY’26 results: High yield, clear path to dividend cover

Real Estate Credit Investments maintained its 3p quarterly dividend, offering a 10.3% yield, while outlining routes to restore dividend cover. Credit performance remains strong, leverage is conservative and the shares continue to trade at a substantial discount to NAV.

RM Assessment targets expanding demand for digital exams

RM Assessment is positioned to benefit as schools and awarding bodies adopt more digital and hybrid examination systems.

Drax takes control of Aldi’s UK EV charging network

Drax will operate and expand around 1,200 electric vehicle chargers across Aldi’s UK store network.

Energy strength and resilient trading updates support the FTSE 100

Higher oil prices and resilient company updates supported a steadier outlook for the FTSE 100.

AI leadership gives emerging markets a stronger strategic position

Emerging markets are gaining a more important role in the global artificial intelligence economy, led by major Asian semiconductor companies with strong positions in advanced computing infrastructure.

    Search